ATE219657T1 - Nasale lösungen - Google Patents

Nasale lösungen

Info

Publication number
ATE219657T1
ATE219657T1 AT99904823T AT99904823T ATE219657T1 AT E219657 T1 ATE219657 T1 AT E219657T1 AT 99904823 T AT99904823 T AT 99904823T AT 99904823 T AT99904823 T AT 99904823T AT E219657 T1 ATE219657 T1 AT E219657T1
Authority
AT
Austria
Prior art keywords
nasal solutions
liquid
nasal
inter alia
relates
Prior art date
Application number
AT99904823T
Other languages
English (en)
Inventor
Matthias Seidel
Christopher Buckley
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Application granted granted Critical
Publication of ATE219657T1 publication Critical patent/ATE219657T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT99904823T 1998-01-30 1999-01-28 Nasale lösungen ATE219657T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98810069 1998-01-30
PCT/EP1999/000555 WO1999038492A1 (en) 1998-01-30 1999-01-28 Nasal solutions

Publications (1)

Publication Number Publication Date
ATE219657T1 true ATE219657T1 (de) 2002-07-15

Family

ID=8235913

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99904823T ATE219657T1 (de) 1998-01-30 1999-01-28 Nasale lösungen

Country Status (12)

Country Link
EP (1) EP1051155B1 (de)
JP (1) JP4603687B2 (de)
AT (1) ATE219657T1 (de)
AU (1) AU741364B2 (de)
CA (1) CA2311530C (de)
DE (1) DE69901936T2 (de)
DK (1) DK1051155T3 (de)
ES (1) ES2180274T3 (de)
IL (1) IL136591A (de)
NZ (1) NZ505919A (de)
PT (1) PT1051155E (de)
WO (1) WO1999038492A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
DE50001217D1 (de) * 1999-06-22 2003-03-13 Boehringer Ingelheim Int Stabile xylometazolin- und oxymetazolinlösung
US7652030B2 (en) * 2001-09-18 2010-01-26 Nycomed Danmark Aps Compositions for treatment of common cold
BG65734B1 (bg) * 2002-02-22 2009-09-30 Био Терапютикс - Еоод Течен мукоадхезивен фармацевтичен състав
AU2003278962B2 (en) * 2002-06-20 2006-11-23 Novartis Consumer Health S.A. Nasal compositions comprising a mucopolysaccharide and propylene glycol
WO2004024187A2 (en) * 2002-09-13 2004-03-25 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
US20040235807A1 (en) * 2003-05-21 2004-11-25 Weinrich Karl P. Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
WO2005004842A2 (en) 2003-06-30 2005-01-20 Alza Corporation Formulations for coated microprojections containing non-volatile counterions
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
JP4956981B2 (ja) * 2005-01-05 2012-06-20 大正製薬株式会社 オキシメタゾリン含有水性組成物
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
US8940796B2 (en) * 2006-02-21 2015-01-27 Wyeth Llc Phenylephrine liquid formulations
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
DE102008007198A1 (de) * 2008-02-01 2009-08-13 Infectopharm Arzneimittel Und Consilium Gmbh Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften
JP2012505236A (ja) * 2008-10-10 2012-03-01 シェーリング コーポレイション コルチコステロイド組成物およびそれの治療方法
PL2759290T3 (pl) 2013-01-24 2020-03-31 Merz Pharma Gmbh & Co. Kgaa Płynny preparat w aerozolu do stosowania donosowego z wydłużonym miejscowym czasem działania
DE102013001151A1 (de) 2013-01-24 2014-07-24 Merz Pharma Gmbh & Co. Kgaa Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit
DE202013000748U1 (de) 2013-01-24 2013-02-19 Merz Pharma Gmbh & Co. Kgaa Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit
WO2014158118A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Suspension composition containing ipratropium and oxymetazoline
WO2014158119A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş Aqueous solution composition containing ipratropium and oxymetazoline
JP6039861B2 (ja) 2013-07-17 2016-12-07 ダウ グローバル テクノロジーズ エルエルシー ヒドロキシアルキルメチルセルロースを含む粘膜適用組成物
WO2015047762A1 (en) * 2013-09-25 2015-04-02 Dow Global Technologies Llc Composition for application to a mucosa comprising a cellulose ether
US20170348230A1 (en) * 2014-12-24 2017-12-07 Jadran-Galenski Laboratorij D.D A nasal composition containing sea water as stability-improving excipient
JP2020516688A (ja) * 2017-04-17 2020-06-11 ヒクマ・ファーマシューティカルズ・ユー・エス・エイ・インコーポレイテッド エピネフリンスプレー製剤
CA3102815A1 (en) * 2018-06-13 2019-12-19 Hikma Pharmaceuticals Usa Inc. Epinephrine spray formulations
MX2021001397A (es) 2018-09-11 2021-04-12 Lead Biotherapeutics Ltd Sistema de nanoparticulas de dispersion mucoadhesiva y metodo de produccion del mismo.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62292719A (ja) * 1986-06-12 1987-12-19 Kaken Pharmaceut Co Ltd 外用澄明水溶性製剤
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPH04327533A (ja) * 1991-04-23 1992-11-17 Lion Corp 抗アレルギー用粘膜局所投与剤
DE69222295T2 (de) * 1992-05-26 1998-04-09 The Procter & Gamble Co., Cincinnati, Ohio Pulverförmige pharmazeutische Zusammensetzung
CA2101126A1 (en) * 1992-08-03 1994-02-04 Yasushi Morita Preparation for local treatment
US5756483A (en) * 1993-03-26 1998-05-26 Merkus; Franciscus W. H. M. Pharmaceutical compositions for intranasal administration of apomorphine
JPH07109228A (ja) * 1993-10-08 1995-04-25 Earth Chem Corp Ltd リゾチーム配合口腔用組成物
EP0689843B1 (de) * 1993-12-17 2003-09-10 Mochida Pharmaceutical Co., Ltd. Lösliches thrombomodulin enthaltende zubereitung
JP3269770B2 (ja) * 1995-03-02 2002-04-02 参天製薬株式会社 再分散性の優れたイオン性高分子配合水性懸濁点眼剤
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
AU9281698A (en) * 1997-10-01 1999-04-23 Wakamoto Pharmaceutical Co., Ltd. O/w emulsion compositions

Also Published As

Publication number Publication date
EP1051155A1 (de) 2000-11-15
ES2180274T3 (es) 2003-02-01
AU741364B2 (en) 2001-11-29
CA2311530C (en) 2008-06-10
DE69901936D1 (de) 2002-08-01
DK1051155T3 (da) 2002-09-16
AU2519899A (en) 1999-08-16
IL136591A (en) 2005-08-31
CA2311530A1 (en) 1999-08-05
NZ505919A (en) 2002-10-25
EP1051155B1 (de) 2002-06-26
WO1999038492A1 (en) 1999-08-05
IL136591A0 (en) 2001-06-14
JP2002501884A (ja) 2002-01-22
JP4603687B2 (ja) 2010-12-22
PT1051155E (pt) 2002-10-31
DE69901936T2 (de) 2002-11-28

Similar Documents

Publication Publication Date Title
ATE219657T1 (de) Nasale lösungen
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
ES2162951T3 (es) Estabilizacion de composiciones de prostaglandina.
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
SE0001899D0 (sv) New compounds
DE60108236D1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
ATE246514T1 (de) Paclitaxel enthaltende arzneimittel
AU3227700A (en) Skin sanitizing compositions
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
BR0014355A (pt) Derivados de sapogenina e seu uso no tratamento de disfunção cognitiva
HUP0101498A1 (hu) Dexmedetomidin alkalmazása nyugtató hatású gyógyszerkészítmények előállítására
TR200100455T2 (tr) Nimesulid içeren topikal farmasötik bileşimler
SE9801494D0 (sv) Novel use
DE69911388D1 (de) Orale antimikrobielle und desodoriende zusammensetzungen
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
DK1092431T3 (da) Lasofoxifenpræparater
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
MXPA03011128A (es) Composicion de sabor y fragancia.
DE60003074D1 (de) Fusidinsäure-derivate
MD1473G2 (ro) Remediu antiherpetic
ATE298564T1 (de) Arzneimittelformulierung enthaltend einen ltb4 antagonisten und einen netzmittel
BR0213463A (pt) Composições farmacêuticas contendo macrólidos
TR200001466T2 (tr) Burun solüsyonları
ATE328864T1 (de) Alanin-2,6-dialkoxyphenylesterderivate als hypnotika
BR0211522A (pt) Tratamento de dor crÈnica com 3-arilóxi-3-fenilpropanaminas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification